These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30690190)

  • 41. Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential.
    Messerli M; Wagner A; Sager R; Mueller M; Baumann M; Surbek DV; Schoeberlein A
    Reprod Sci; 2013 Dec; 20(12):1455-64. PubMed ID: 23670950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.
    Sabapathy V; Sundaram B; V M S; Mankuzhy P; Kumar S
    PLoS One; 2014; 9(4):e93726. PubMed ID: 24736473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of mesenchymal stromal cells derived from rabbit bone marrow and Wharton's jelly for adipose tissue engineering.
    Li L; Dong J; He Y; Mao W; Tang H; Dong Y; Lyu F
    Connect Tissue Res; 2020 Nov; 61(6):537-545. PubMed ID: 31185754
    [No Abstract]   [Full Text] [Related]  

  • 45. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
    Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
    Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells.
    Thakur G; Bok EY; Kim SB; Jo CH; Oh SJ; Baek JC; Park JE; Kang YH; Lee SL; Kumar R; Rho GJ
    Eur J Cell Biol; 2022; 101(3):151245. PubMed ID: 35667339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. H3K9ac of TGFβRI in human umbilical cord: a potential biomarker for evaluating cartilage differentiation and susceptibility to osteoarthritis via a two-step strategy.
    Qi Y; Li B; Wen Y; Yang X; Chen B; He Z; Zhao Z; Magdalou J; Wang H; Chen L
    Stem Cell Res Ther; 2021 Mar; 12(1):163. PubMed ID: 33663609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.
    Batsali AK; Kastrinaki MC; Papadaki HA; Pontikoglou C
    Curr Stem Cell Res Ther; 2013 Mar; 8(2):144-55. PubMed ID: 23279098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions.
    Russo E; Lee JY; Nguyen H; Corrao S; Anzalone R; La Rocca G; Borlongan CV
    Stem Cell Rev Rep; 2020 Jun; 16(3):585-595. PubMed ID: 32185666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
    Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
    Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturing.
    Gatta V; D'Aurora M; Lanuti P; Pierdomenico L; Sperduti S; Palka G; Gesi M; Marchisio M; Miscia S; Stuppia L
    BMC Genomics; 2013 Sep; 14():635. PubMed ID: 24053474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased internalization of Staphylococcus aureus and cytokine expression in human Wharton's jelly mesenchymal stem cells.
    Josse J; Velard F; Mechiche Alami S; Brun V; Guillaume C; Kerdjoudj H; Lamkhioued B; Gangloff SC
    Biomed Mater Eng; 2014; 24(1 Suppl):27-35. PubMed ID: 24928915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between adult and foetal adnexa derived equine post-natal mesenchymal stem cells.
    Merlo B; Teti G; Lanci A; Burk J; Mazzotti E; Falconi M; Iacono E
    BMC Vet Res; 2019 Aug; 15(1):277. PubMed ID: 31375144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Insights into the Stemness and Immune Privilege of Mesenchymal Stem Cells from Human Wharton Jelly by Single-Cell RNA Sequencing.
    Leng Z; Li L; Zhou X; Dong G; Chen S; Shang G; Kou H; Yang B; Liu H
    Med Sci Monit; 2022 Feb; 28():e934660. PubMed ID: 35153292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells.
    Sun B; Shi L; Shi Q; Jiang Y; Su Z; Yang X; Zhang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):314. PubMed ID: 30442201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of MRI on stemness properties of Wharton's jelly-derived mesenchymal stem cells.
    Tashakori M; Asadi F; Khorram FS; Manshoori A; Hosseini-Chegeni A; Moghadam FM; Kamalabadi MA; Yousefi-Ahmadipour A
    Cell Tissue Bank; 2023 Sep; 24(3):523-533. PubMed ID: 36526818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro anti-leukemic effect of Wharton's jelly derived mesenchymal stem cells.
    Süleymanoğlu M; Erol Bozkurt A; Abatay Sel F; Özdemir İA; Savran Oğuz F; Kuruca DS; Aktaş Z; Karakaş Z; Öncül MO
    Mol Biol Rep; 2024 Apr; 51(1):595. PubMed ID: 38683436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obestatin can potentially differentiate Wharton's jelly mesenchymal stem cells into insulin-producing cells.
    El-Asfar RK; Kamal MM; Abd El-Razek RS; El-Demerdash E; El-Mesallamy HO
    Cell Tissue Res; 2018 Apr; 372(1):91-98. PubMed ID: 29159483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.